Growth Metrics

Tandem Diabetes Care (TNDM) Long-Term Investments (2016 - 2026)

Tandem Diabetes Care filings provide 5 years of Long-Term Investments readings, the most recent being $60.4 million for Q4 2025.

  • On a quarterly basis, Long-Term Investments fell 18.98% to $60.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $60.4 million, a 18.98% decrease, with the full-year FY2025 number at $60.4 million, down 18.98% from a year prior.
  • Long-Term Investments hit $60.4 million in Q4 2025 for Tandem Diabetes Care, down from $64.9 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $74.5 million in Q4 2024 to a low of $60.4 million in Q4 2025.